A preprint study posted late last week on the server medRxiv reveals that the current Moderna COVID-19 vaccine is 53% ...
Moderna Inc MRNA -11.5% Get Free Report shares were down 13.5% at $26.88 and Novavax Inc NVAX -9.02% Get Free Report shares ...
Shares in Moderna, Vaxcyte, Novavax and BioNTech all fell Monday after Peter Marks, head of the FDA office that reviews ...
If Medicaid is taken away, children could still receive vaccination coverage through a variety of other programs, including the Children's Health Insurance Program or the Title V Maternal and Child ...
Vaccine makers Moderna Inc (NASDAQ:MRNA) and Novavax Inc (NASDAQ:NVAX) are facing selling pressure on Wednesday following reports suggesting the Trump administration will end support for Gavi.
Moderna stock has dropped more than 70% over the past year. The company’s coronavirus vaccine no longer is driving outsized growth -- and Moderna is still in the process of ushering in newer ...
Ron DeSantis asked the CDC earlier this month to stop recommending mRNA COVID-19 vaccines for children ... profile and mechanism of action,” a Moderna spokesperson told PharmaVoice.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback